| 000 | 01712 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517105507.0 | ||
| 264 | 0 | _c20160831 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1857-9345 | ||
| 024 | 7 |
_a10.1515/prilozi-2015-0067 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCiriviri, Jasmin | |
| 245 | 0 | 0 |
_aA Two Phase Treatment of an Infected Hip Endoprosthesis. _h[electronic resource] |
| 260 |
_bPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) _c2015 |
||
| 300 |
_a195-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xadverse effects |
| 650 | 0 | 4 | _aCoated Materials, Biocompatible |
| 650 | 0 | 4 |
_aDebridement _xadverse effects |
| 650 | 0 | 4 |
_aDevice Removal _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHip Joint _xpathology |
| 650 | 0 | 4 |
_aHip Prosthesis _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNecrosis |
| 650 | 0 | 4 | _aProsthesis Design |
| 650 | 0 | 4 |
_aProsthesis-Related Infections _xdiagnosis |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTalevski, Darko | |
| 700 | 1 | _aNestorovski, Zoran | |
| 700 | 1 | _aVraniskoski, Tode | |
| 700 | 1 | _aMishevska-Perchinkova, Snežana | |
| 773 | 0 |
_tPrilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) _gvol. 36 _gno. 2 _gp. 195-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/prilozi-2015-0067 _zAvailable from publisher's website |
| 999 |
_c26250833 _d26250833 |
||